Specification: |
The Buspirone with the cas number 21535-47-7, is also called (1)8-(4-(4-(2-Pyrimidinyl)-1-piperizinyl)butyl)-8-azaspiro(4,5)decane-7,9-dione; (2) Ansial ; (3) Buspirona ; (4) Buspirone ; (5) Buspironum ; (6)8-Azaspiro(4,5)decane-7,9-dione, 8-(4-(4-(2-pyrimidinyl)piperizinyl)butyl)-; (7)8-Azaspiro(4.5)decane-7,9-dione, 8-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-. It belongs to Serotonin receptor product categories.
Properties of Bolvidon are: (1)ACD/LogP: 3.43 ; (2)# of Rule of 5 Violations: 0 ; (3)ACD/LogD (pH 5.5): 2.26 ; (4)ACD/LogD (pH 7.4): 3.37 ; (5)ACD/BCF (pH 5.5): 16.18 ; (6)ACD/BCF (pH 7.4): 205.29 ; (7)ACD/KOC (pH 5.5): 118.63 ; (8)ACD/KOC (pH 7.4): 1504.97 ; (9)#H bond acceptors: 7 ; (10)#H bond donors: 0 ; (11)#Freely Rotating Bonds: 6 ; (12)Polar Surface Area: 69.64 Å2 ; (13)Index of Refraction: 1.603 ; (14) Molar Refractivity: 106.83 cm3 ; (15)Molar Volume: 310.6 cm3 ; (16)Polarizability: 42.35 ×10-24 cm3 ; (17)Surface Tension: 62.3 dyne/cm ; (18)Density: 1.24 g/cm3 ; (19)Flash Point: 325.1 °C ; (20)Enthalpy of Vaporization: 91.11 kJ/mol ; (21)Boiling Point: 613.9 °C at 760 mmHg ; (22)Vapour Pressure: 5.24E-15 mmHg at 25°C
The Buspirone shows no potential for addiction or dependence, and the development of tolerance has not been observed. The main disadvantage of Buspirone (CAS NO.36505-84-7) is that it may take several weeks before its anxiolytic effects become noticeable. Often patients have to be initially co-treated with a benzodiazepine for an immediate anxiolytic effect. It functions as a serotonin 5-HT1A receptor partial agonist. Side effects have been reported, but are not more frequent than those encountered with placebo.
The Buspirone can be obtained by reaction of 2-piperazino-pyrimidine with 8-aza-spiro[4.5]decane-7,9-dione and 1,4-dibromo-butane. This reaction progress with triethylbenzylammonium bromide as catalytic agent, reflux in xylene for 3 h, or reflux for 5 h. This reaction can also goes with other imides and catalysts, variation of reaction time, also in toluene and also 1-(2-quinolinyl)piperazine.
++
You can still convert the following datas into molecular structure :
1. SMILES: O=C1N(C(=O)CC2(C1)CCCC2)CCCCN4CCN(c3ncccn3)CC4
2. InChI: InChI=1/C21H31N5O2/c27-18-16-21(6-1-2-7-21)17-19(28)26(18)11-4-3-10-24-12-14-25(15-13-24)20-22-8-5-9-23-20/h5,8-9H,1-4,6-7,10-17H2
The Buspirone toxic data can be showed in the following sheet.
Organism |
Test Type |
Route |
Reported Dose (Normalized Dose) |
Effect |
Source |
human |
TDLo |
unreported |
399mg/kg/19D- (399mg/kg) |
BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY) |
Drugs of the Future. Vol. 1, Pg. 409, 1976. |
|